
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. (FDMT)
WebsitePrice
Market cap
Next catalystExpected Q2 20274D-150 — wet AMD: PRISM and 4FRONT · Phase 3 dataSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
History / paused
FDMT PR & News
PR & News
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc.